Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells

Details for Australian Patent Application No. 2010214637 (hide)

Owner Proyecto De Biomedicina Cima, S.L.

Inventors Qian, Cheng; Smerdou Picazo, Christian; Prieto Valtuena, Jesus; Guan, Min

Agent Intellepro

Pub. Number AU-B-2010214637

Parent 2005244625

Filing date 20 August 2010

Wipo publication date 16 September 2010

Acceptance publication date 26 April 2012

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

9 September 2010 Complete Application Filed

16 September 2010 Application Open to Public Inspection

  Published as AU-B-2010214637

26 April 2012 Application Accepted

  Published as AU-B-2010214637

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214638-Vascular hole closure device

2010214636-Compositions and methods for treating and preventing cardiomyopathy and heart disease